VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 71 filers reported holding VERONA PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,227,802 | +35.0% | 934,221 | +75.1% | 0.01% | +33.3% |
| Q2 2023 | $11,277,852 | +101878.9% | 533,484 | -3.1% | 0.01% | 0.0% |
| Q1 2023 | $11,059 | +34.8% | 550,762 | +75.4% | 0.01% | +20.0% |
| Q4 2022 | $8,206 | -99.0% | 314,053 | +295.8% | 0.01% | – |
| Q3 2022 | $811,000 | +505.2% | 79,340 | +196.1% | 0.00% | – |
| Q1 2022 | $134,000 | +25.2% | 26,799 | +67.8% | 0.00% | – |
| Q4 2021 | $107,000 | +32.1% | 15,969 | +8.0% | 0.00% | – |
| Q3 2021 | $81,000 | +19.1% | 14,786 | +35.1% | 0.00% | – |
| Q3 2020 | $68,000 | – | 10,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |